Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2010
07/29/2010WO2010083872A2 Materials for organic electroluminescence devices
07/29/2010WO2010004457A3 Process for the preparation of 3, 4-dihydro-2h-thien [3, 2-e] -1, 2-thiazin-4-ol 1, 1 -dioxide derivatives and intermediates
07/29/2010US20100190868 Photochromic and electrochromic compounds and synthesis and use thereof
07/29/2010US20100190831 Gpr120 receptor agonists and uses thereof
07/29/2010US20100190779 Viral polymerase inhibitors
07/29/2010US20100190766 Antibacterial agents
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/29/2010US20100187504 Diamine derivatives and organic electronic device using the same
07/29/2010CA2749410A1 Novel microbiocides
07/28/2010EP2210884A2 Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propionic acid and 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol as well as salts thereof
07/28/2010EP2210883A2 Heterocyclic fused selenophene monomers
07/28/2010EP2210876A1 Heterocyclic compound
07/28/2010EP2209773A2 Novel thiophene-based dye and preparation thereof
07/28/2010EP1814848B1 2,3,4-substituted-cyclopentanones as therapeutic agents
07/28/2010EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists
07/28/2010CN1548434B Benzothiophene compounds and their preparation and medicine use
07/28/2010CN101787012A Substituted 2'-butylthio-[3, 3'] bithiophene aldehyde compound and preparation method thereof
07/28/2010CN101293861B Method for preparing aryl sulfone derivatives
07/27/2010US7763739 bidentante optionally N-containing P-ligands embracing a two-ring-system; for transition metal complexes to be used as catalysts
07/27/2010CA2436659C Cannabinoid receptor ligands
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010081894A1 Cyclopentadione derived herbicides
07/22/2010WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
07/22/2010WO2010003942A3 Preparation of duloxetine and its pharmaceutically acceptable salts by the use of asymmetric transfer hydrogenation process
07/22/2010US20100184974 Protease Inhibitors
07/22/2010US20100184768 Isoprenyl Compounds and Methods Thereof
07/22/2010US20100184600 Stable Ethylene Inhibiting Compounds and Methods for Their Preparation
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010DE102009005289A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
07/22/2010DE102009005288A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
07/22/2010CA2749216A1 Cyclopentadione derived herbicides
07/22/2010CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP2207772A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor
07/21/2010EP2207771A2 Polymorphs of enantiopure erdosteine
07/21/2010EP1079825B1 Compounds that inhibit the binding of integrins to their receptors
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/20/2010US7759502 Stilbene derivatives and their use for binding and imaging amyloid plaques
07/20/2010US7759501 via reducing (Z)-N-monoalkyl-3-oxo-3-(2-thienyl)propenamine in presence of carboxylic acid
07/20/2010US7759500 solventizing; liquid chromatography
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759390 chemokine receptor 9(CCR9) antagonists such as, 5-Chloro-thiophene-2-sulfonic acid (4-cyano-2-methyl-phenyl)-amide, used for treating autimmune and inflammatory diseases, transplantat rejection and cancer
07/20/2010US7759373 nitrogen-containing 5-membered heterocyclic compound
07/20/2010CA2486399C Calcium receptor modulating agents
07/15/2010WO2010080537A1 Gpr120 receptor agonists and uses thereof
07/15/2010WO2010080398A1 Sulfonamides as trpm8 modulators
07/15/2010WO2010080397A1 Sulfamides as trpm8 modulators
07/15/2010WO2010079404A2 An improved process for the preparation of duloxetine and salts thereof
07/15/2010US20100179326 Benzamide derivative
07/15/2010US20100179168 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
07/15/2010CA2758736A1 An improved process for the reparation of duloxetine and salts thereof
07/15/2010CA2747662A1 Sulfonamides as trpm8 modulators
07/15/2010CA2747637A1 Sulfamides as trpm8 modulators
07/15/2010CA2746762A1 Gpr120 receptor agonists and uses thereof
07/14/2010EP2206709A2 Thiophene derivatives as antiviral agents for flavivirus infection
07/14/2010EP2205608A1 Preparation of dihydrothieno ý3, 2-d¨pyrimidines and intermediates used therein
07/14/2010EP2205563A2 Novel histone deacetylase inhibitors
07/14/2010EP1486494B1 N-substituted benzothiophenesulfonamide derivative
07/14/2010CN101778834A Novel herbicides
07/14/2010CN101778818A Aromatic sulfonium salt compound
07/14/2010CN101775003A Benzothiophene derivative, preparation method and application thereof
07/14/2010CN101775002A Method for preparing strontium ranelate
07/14/2010CN101775001A Method for synthesizing clopidogrel hydrogen sulfate intermediate by adopting solid acid catalytic esterification
07/13/2010US7754892 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
07/13/2010US7754890 Arylsulfones and uses related thereto
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/13/2010CA2567776C Vasopressin v1a antagonists
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010076033A1 Toluidine sulfonamides and their use
07/08/2010WO2010075869A1 Toluidine sulfonamides and their use
07/08/2010WO2009147031A3 Oxime ester photoinitiators
07/08/2010US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia
07/08/2010US20100174088 Process for the preparation of benzimidazol thienylamine compounds and derivatives thereof useful as sodium/proton exchanger type 3 inhibitors
07/08/2010US20100173981 Therapeutic compounds
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
07/08/2010US20100173774 Novel herbicides
07/08/2010CA2746790A1 Toluidine sulfonamides and their use
07/07/2010CN101772508A Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex
07/07/2010CN101768150A 2-[3-cyano-4-isobutoxy phenyl]-4-methylthiazol-5-formic acid crystal forms and preparation method thereof
07/07/2010CN101768090A Organic light-emitting material 4,4 '-bis-arylation acetenyl azobenzol compound, synthesis method and application
07/06/2010US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects
07/06/2010US7750040 G protein-coupled receptor S1P1/EDG1 agonists; low dosage, long lasting immunosuppressive effect; such as 1,1,2-trimethyl-1,1a,5,5a-tetrahydro-3-thia-cyclopropa[a]pentalene-4-carboxylic acid 2,4-dimethoxy-benzylamide
07/06/2010US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection
07/06/2010US7750012 leukotriene A4 hydrolase inhibitors such as 4-{4-[4-(4-Iodo-phenoxy)-phenyl]-piperazin-1-yl]-butyric acid methyl ester, used for the treatment, prevention and/or prophylaxis of inflammatory diseases and disorders
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010074327A1 Halogen-containing organosulfur compounds and use thereof for controlling arthropod pest
07/01/2010WO2010074272A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
07/01/2010WO2010073124A2 Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
07/01/2010WO2010072813A1 Competitive inhibitors of type ii dehydroquinase enzyme
07/01/2010WO2009150238A3 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
07/01/2010WO2009047615A3 Novel histone deacetylase inhibitors
07/01/2010US20100168217 Sulfamatobenzothiophene derivatives
07/01/2010US20100168176 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
07/01/2010US20100168070 Compounds for the treatment of alzheimer's disease
07/01/2010US20100167927 Substituted Amino-Thiourea Compounds For Combating Animal Pests
07/01/2010US20100166881 Novel IDO Inhibitors and Methods of Use Thereof
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 329